Vessel fractions in tumor xenografts depicted by flow- or contrast-sensitive three-dimensional high-frequency Doppler ultrasound respond differently to antiangiogenic treatment

Cancer Research

Volumn 68, Issue 17, 2008, Pages 7042-7049

  Palmowski, Moritz ^a   Huppert, Jochen ^a   Hauff, Peter ^b   Reinhardt, Michael ^b   Schreiner, Karin ^a   Socher, Michaela A ^a   Hallscheidt, Peter ^c   Kauffmann, Guenter W ^c   Semmler, Wolfhard ^a   Kiessling, Fabian ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b BAYER PHARMA AG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOACRYLATE DERIVATIVE; SUNITINIB; ANGIOGENESIS INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW; BLOOD VESSEL; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DRUG EFFECT; FEMALE; HEART RATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TUMOR GROWTH; TUMOR XENOGRAFT; VASCULARIZATION; ANIMAL; DOPPLER FLOWMETRY; EXPERIMENTAL NEOPLASM; IMMUNOHISTOCHEMISTRY; METHODOLOGY; NUDE MOUSE;

ANGIOGENESIS INHIBITORS; ANIMALS; FEMALE; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; ULTRASONOGRAPHY, DOPPLER;

EID: 52049113198     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-0285     Document Type: Article

References (30)

1. Folkman J. Angiogenesis. Annu Rev Med 2006;57:1-18.
2. Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature 2005;15:967-74.
3. Mendel DB, Laird AD, Xin X, et al. In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship. Clin Cancer Res 2003;9:327-937.
4. Neeman M, Gilad AA, Dafni H, Cohen B. Molecular imaging of angiogenesis. J Magn Reson Imaging 2007;25:1-12.
5. Kiessling F, Jugold M, Woenne EC, Brix G. Noninvasive assessment of vessel morphology and function in tumors by magnetic resonance imaging. Eur Radiol 2007;17:2136-48.
6. Persigehl T, Bieker R, Matuszewski L, et al. Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice. Radiology 2007;244:449-56.
7. Hakime A, Peddi H, Hines-Peralta AU, et al. CT perfusion for determination of pharmacologically mediated blood flow changes in an animal tumor model. Radiology 2007;243:712-9.
8. Kiessling F, Greschus S, Lichy MP, et al. Volumetric computed tomography (VCT): a new technology for noninvasive, high-resolution monitoring of tumor angiogenesis. Nat Med 2004;10:1133-8.
9. Dawson P. Functional imaging in CT. Eur J Radiol 2006;60:331-40.
10. Gambhir SS. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2002;2:683-93.
11. Laking GR, Price PM. Positron emission tomographic imaging of angiogenesis and vascular function. Br J Radiol 2003;76:50-9.
12. Fleischer AC, Niermann KJ, Donnelly EF, et al. Sonographic depiction of microvessel perfusion: principles and potential. J Ultrasound Med 2004;23:1499-506.
13. Korpanty G, Carbon JG, Grayburn PA, Fleming JB, Brekken RA. Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature. Clin Cancer Res 2007;13:323-30.
14. Donnelly E., Geng L, Wojcicki WE, Fleischer AC, Hallahan DE. Quantified power Doppler US of tumor blood flow correlates with microscopic quantification of tumor blood vessels. Radiology 2001;219:166-70.
15. Iordanescu I, Becker C, Zetter B, Dunning P, Taylor GA. Tumor vascularity: evaluation in a murine model with contrast enhanced color Doppler US effect of angiogenesis inhibitors. Radiology 2002;222:460-7.
16. Delorme S, Haberkorn U, Kinscherf R, et al. Changes of tumor vascularity during gene therapy monitored with color Doppler US. Ultrasound Med Biol 2001;27:1595-603.
17. Forsberg F, Ro RJ, Potoczek M, et al. Assessment of angiogenesis: implications for ultrasound imaging. Ultrasonics 2004;42:325-30.
18. Reinhardt M, Hauff P, Briel A, et al. Sensitive particle acoustic quantification (SPAQ): a new ultrasound-based approach for the quantification of ultrasound contrast media in high concentrations. Invest Radiol 2005;40:2-7.
19. Kiessling F, Le-Huu M, Kunert T, et al. Improved correlation of histological data with DCE MRI parameter maps by 3D reconstruction, reslicing and parameterization of the histological images. Eur Radiol 2005;15:1079-86.
20. Foster FS, Zhang MY, Zhou YQ, et al. A new ultrasound instrument for in vivo microimaging of mice. Ultrasound Med Biol 2002;28:1165-72.
21. Goertz DE, Yu JL, Kerbel RS, Burns PN, Foster FS. High-frequency Doppler ultrasound monitors the effects of antivascular therapy on tumor blood flow. Cancer Res 2002;62:6371-5.
22. Olbrich C, Hauff P, Scholle F, et al. The in vitro stability of air-filled polybutylcyanoacrylate microparticles. Biomaterials 2006;27:3549-59.
23. Palmowski M, Huppert J, Hauff P, et al. Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of anti-angiogenic therapy effects. Mol Cancer Ther 2008;7:101-9.
24. Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242-8.
25. Jugold M, Palmowski M, Huppert J, et al. Volumetric high frequency Doppler ultrasound enables the assessment of early antiangiogenic therapy effects on tumor xenografts in nude mice. Eur Radiol 2008;18:753-8.
26. Brown EB, Campbell RB, Tsuzuki Y, et al. In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nat Med 2001;7:864-8.
27. Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242-8.
28. Jain RK. Molecular regulation of vessel maturation. Nat Med 2003;9:685-93.
29. Kiessling F, Farhan N, Lichy MP, et al. Dynamic contrast-enhanced magnetic resonance imaging rapidly indicates vessel regression in human squamous cell carcinomas grown in nude mice caused by VEGF receptor 2 blockade with DC101. Neoplasia 2004;6:213-23.
30. Palmowski M, Morgenstern B, Hauff P, et al. Pharmacodynamics of streptavidin-coated cyanoacrylate microbubbles designed for molecular ultrasound imaging. Invest Radiol 2008;43:162-9.